PER

2.47%

7.9¢ percheron therapeutics limited

Pretty much agree with everything you said kpkg except the drugs...

First 11 Last

Share
Profile

Follow
bolz

165 Posts.

12/07/17

06:54

Post #: 25807347
Share

Originally posted by kpkg ↑

After 16 years of failing to get one drug permanently licensed out and registered it's hardly any wonder.
Was it 2014 or 2015 they said it would take 12 months to relicense out 1103 and they were exchanging emails on 1102 with potential interested parties.
That all amounted to nix and their word means nothing imo. Just the same as the touted revenues from the Early access program that disappeared with great mystery.
And people blame the negative posts for holding the stock back . Wow that's rich.
...this company has burnt so many investors in the past by not delivering it's hardly any wonder that there is no market confidence.
Meanwhile they plan on flogging off 20% of the company at all time historical lows ...for an amount that barely covers the cost of Diamond for another 2 years.
And this is meant to be a positive Ann ??I mean seriously you guys ...are you all that blind??
...as for the international board comment well they haven't attracted much since their appointment (coming up to 2 years?)but we did see a spectacular slide in the sp.
Really the amazing thing is that this all centres around some first generation antisense compounds that are becoming increasingly obsolete imo
The new generation of antisense drugs are more potent and supposedly less toxic so it's hardly any wonder they have not been able to find anyone on this planet to take them up.
Seriously it's been 7 years ? Since Teva handed back 1102 for something to do with a failed monkey study and now everyone gets excited that they dug up some old data. If any of the data was that good then it sure as hell wouldn't take the better part of a decade to license out 1102 again....but here we are with patent life running out and new drugs superseding.
That is the reality and there are all the above reasons and more for why and where this capital sucking company is where it is.

Expand

Pretty much agree with everything you said kpkg except the drugs are second generation. Wouldn't matter if they were the latest and greatest the BOD would probably find a way to make a meal of it.

Last edited by bolz: 12/07/17

ANP Price at posting: 3.7¢ Sentiment: None Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

What each US election outcome would mean for Australian companies & investors

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

There are more pages in this discussion • 42 more messages in this thread...

First 11 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.9¢		Change -0.002(2.47%)		Mkt cap ! $81.90M

Open	High	Low	Value	Volume
8.0¢	8.0¢	7.9¢	$230.1K	2.904M

Buyers (Bids)

No.	Vol.	Price($)
1	51000	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	163520	2

View Market Depth

No.	Vol.	Price($)
1	51000	0.079
18	1244001	0.078
10	1037506	0.077
9	894271	0.076
10	1100649	0.075

Price($)	Vol.	No.
0.080	163520	2
0.081	344626	2
0.082	150000	1
0.083	368750	3
0.084	200000	1

Last trade - 15.57pm 01/11/2024 (20 minute delay)

PER (ASX) Chart

Pretty much agree with everything you said kpkg except the drugs...

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

What each US election outcome would mean for Australian companies & investors

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Pretty much agree with everything you said kpkg except the drugs...

Top Stories

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

What each US election outcome would mean for Australian companies & investors

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News